XML 17 R6.htm IDEA: XBRL DOCUMENT v3.23.2
STATEMENTS OF SHAREHOLDERS' EQUITY (UNAUDITED) - USD ($)
$ in Thousands
Total
Class A common stock
Class B common stock
Common stock
Class A common stock
Common stock
Class B common stock
Additional paid-in-capital
Accumulated other comprehensive (loss) income
Retained earnings
Retained earnings
Class A common stock
Retained earnings
Class B common stock
Treasury stock
Deferred compensation
Beginning balance at Dec. 31, 2021 $ 1,342,478     $ 1,992 $ 178 $ 16,496 $ (25,288) $ 2,495,190     $ (1,167,828) $ 21,738
Increase (decrease) in shareholders' equity                        
Net income 68,619             68,619        
Other comprehensive income (loss) (25,189)           (25,189)          
Dividends declared:   $ (51,270) $ (423)           $ (51,270) $ (423)    
Net purchase of treasury stock [1] (15)         (15)         0  
Deferred compensation 0                   (802) 802
Rabbi trust distribution [2] 0                   298 (298)
Ending balance at Mar. 31, 2022 1,334,200     1,992 178 16,481 (50,477) 2,512,116     (1,168,332) 22,242
Beginning balance at Dec. 31, 2021 1,342,478     1,992 178 16,496 (25,288) 2,495,190     (1,167,828) 21,738
Increase (decrease) in shareholders' equity                        
Net income 148,766                      
Other comprehensive income (loss) (48,437)           (48,437)          
Ending balance at Jun. 30, 2022 1,339,406     1,992 178 16,481 (73,725) 2,540,570     (1,169,140) 23,050
Beginning balance at Mar. 31, 2022 1,334,200     1,992 178 16,481 (50,477) 2,512,116     (1,168,332) 22,242
Increase (decrease) in shareholders' equity                        
Net income 80,147             80,147        
Other comprehensive income (loss) (23,248)           (23,248)          
Dividends declared:   (51,270) (423)           (51,270) (423)    
Net purchase of treasury stock [1] 0         0         0  
Deferred compensation 0                   (907) 907
Rabbi trust distribution [2] 0                   99 (99)
Ending balance at Jun. 30, 2022 1,339,406     1,992 178 16,481 (73,725) 2,540,570     (1,169,140) 23,050
Beginning balance at Dec. 31, 2022 1,448,408     1,992 178 16,481 (7,414) 2,583,261     (1,168,949) 22,859
Increase (decrease) in shareholders' equity                        
Net income 86,241             86,241        
Other comprehensive income (loss) 7,752           7,752          
Dividends declared:   (54,965) (454)           (54,965) (454)    
Net purchase of treasury stock [1] (15)         (15)         0  
Deferred compensation 0                   (822) 822
Rabbi trust distribution [2] 0                   416 (416)
Ending balance at Mar. 31, 2023 1,486,967     1,992 178 16,466 338 2,614,083     (1,169,355) 23,265
Beginning balance at Dec. 31, 2022 1,448,408     1,992 178 16,481 (7,414) 2,583,261     (1,168,949) 22,859
Increase (decrease) in shareholders' equity                        
Net income 204,093                      
Other comprehensive income (loss) 3,264           3,264          
Ending balance at Jun. 30, 2023 1,544,912     1,992 178 16,466 (4,150) 2,676,516     (1,168,380) 22,290
Beginning balance at Mar. 31, 2023 1,486,967     1,992 178 16,466 338 2,614,083     (1,169,355) 23,265
Increase (decrease) in shareholders' equity                        
Net income 117,852             117,852        
Other comprehensive income (loss) (4,488)           (4,488)          
Dividends declared:   $ (54,965) $ (454)           $ (54,965) $ (454)    
Net purchase of treasury stock [1] 0         0         0  
Deferred compensation 0                   (621) 621
Rabbi trust distribution [2] 0                   1,596 (1,596)
Ending balance at Jun. 30, 2023 $ 1,544,912     $ 1,992 $ 178 $ 16,466 $ (4,150) $ 2,676,516     $ (1,168,380) $ 22,290
[1] Net purchases of treasury stock in 2023 and 2022 include the repurchase of our Class A common stock in the open market that were subsequently distributed to satisfy stock-based compensation awards.
[2] Distributions of our Class A shares were made from the rabbi trust to five incentive compensation deferral plan participants in 2023 and two in 2022.